Following Unanimous Ruling from Superior Court of Peru Confirming Company’s Title to 32 Disputed Concessions, INGEMMET and MINEM Petition the Supreme Court in a Final Attempt to Reverse the Ruling
Go back to Following Unanimous Ruling from Superior Court of Peru Confirming Company’s Title to 32 Disputed Concessions, INGEMMET and MINEM Petition the Supreme Court in a Final Attempt to Reverse the Ruling| (NASDAQ: AMLI) | Delayed: 0.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.38 | 52 Week High | $ | |||
| Open | $0.38 | 52 Week Low | $ | |||
| Day High | $0.38 | P/E | N/A | |||
| Day Low | $0.38 | EPS | $ | |||
| Volume | 177,026,249 | |||||
| Elite Pharmaceuticals (NASDAQ: LI) | Delayed: 12.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.63 | 52 Week High | $35.22 | |||
| Open | $12.63 | 52 Week Low | $0.98 | |||
| Day High | $12.63 | P/E | N/A | |||
| Day Low | $12.63 | EPS | $-0.86 | |||
| Volume | 39,589 | |||||

